Targeting Neutrophil α9 Improves Functional Outcomes After Stroke in Mice With Obesity-Induced Hyperglycemia.
Rakesh B PatelNirav DhaneshaBrijesh SutariyaMadankumar GhatgePrakash DoddapattarTarun BarbhuyanMariia KumskovaEnrique C LeiraAnil K ChauhanPublished in: Stroke (2023)
Genetic ablation of neutrophil-specific α9 or pharmacological inhibition improves long-term functional outcomes after stroke in mice with obesity-induced hyperglycemia, most likely by limiting thrombo-inflammation.